Recro Pharma, Inc. (REPH) financial statements (2021 and earlier)

Company profile

Business Address 490 LAPP ROAD
MALVERN, PA 19355
State of Incorp. PA
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments24193964642020
Cash and cash equivalents24193961642020
Short-term investments   3   
Receivables91413101090
Inventory, net of allowances, customer advances and progress billings1215111099 
Inventory1215111099 
Prepaid expense     11
Contract with customer, asset795
Deferred costs     1 
Other undisclosed current assets23431  
Total current assets:54607187853920
Noncurrent Assets
Operating lease, right-of-use asset 0
Property, plant and equipment444246393738 
Intangible assets, net (including goodwill)5839414446 
Goodwill446666 
Intangible assets, net (excluding goodwill)1332353740 
Deferred costs      3
Deferred tax assets, net 191716 
Other undisclosed noncurrent assets0     (3)
Total noncurrent assets:4950849998100 
TOTAL ASSETS:10311015518618313920
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6519181451
Accounts payable2158421
Accrued liabilities5414101031
Employee-related liabilities      0
Debt10  25 
Disposal group, including discontinued operation 1     
Business combination, contingent consideration, liability  1032   
Other undisclosed current liabilities      (0)
Total current liabilities:8629501691
Noncurrent Liabilities
Long-term debt and lease obligation10811164542225 
Long-term debt, excluding current maturities10811064542225 
Operating lease, liability 0
Liabilities, other than long-term debt1 8150   
Deferred revenue1 
Business combination, contingent consideration, liability  8150   
Other undisclosed noncurrent liabilities0 147364 
Total noncurrent liabilities:1101111461079589 
Total liabilities:118117175157111981
Stockholders' equity
Stockholders' equity attributable to parent(14)(7)(20)29724019
Common stock0000000
Additional paid in capital2202001691401337153
Accumulated other comprehensive loss   (0)   
Accumulated deficit(234)(207)(188)(111)(61)(31)(34)
Total stockholders' equity:(14)(7)(20)29724019
TOTAL LIABILITIES AND EQUITY:10311015518618313920

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues669977726952 
Cost of revenue(54)(53)(47)(46)(42)(32) 
Cost of goods and services sold(54)(51)(43)(38)(37)(28) 
Gross profit:124631262820 
Operating expenses(21)(22)(85)(66)(54)(27)(12)
Operating income (loss):(8)24(54)(40)(26)(7)(12)
Nonoperating income (expense)  1000(4)
Investment income, nonoperating  10000
Interest and debt expense(19)(20)(9)(12)(6)(6)(4)
Income (loss) from continuing operations before equity method investments, income taxes:(28)4(62)(52)(31)(13)(20)
Other undisclosed income from continuing operations before income taxes 20     
Income (loss) from continuing operations before income taxes:(28)24(62)(52)(31)(13)(20)
Income tax expense (benefit)7(1)(17)2116 
Income (loss) from continuing operations:(20)23(80)(50)(30)3(20)
Loss from discontinued operations (23)     
Income (loss) before gain (loss) on sale of properties:(20)(1)(80)(50)(30)3(20)
Other undisclosed net loss(7)(18)     
Net income (loss):(28)(19)(80)(50)(30)3(20)
Other undisclosed net income attributable to parent      4
Net income (loss) attributable to parent:(28)(19)(80)(50)(30)3(16)
Preferred stock dividends and other adjustments      (1)
Net income (loss) available to common stockholders, basic:(28)(19)(80)(50)(30)3(17)
Dilutive securities, effect on basic earnings per share     (1) 
Net income (loss) available to common stockholders, diluted:(28)(19)(80)(50)(30)2(17)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(28)(19)(80)(50)(30)3(20)
Other comprehensive income (loss)  0(0)   
Comprehensive income (loss), net of tax, attributable to parent:(28)(19)(80)(50)(30)3(20)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: